Want to see RMTG full AI Analyst Report?
Regenerative Medical Technology Group (RMTG) Financial Statements
Regenerative Medical Technology Group Financial Overview
Regenerative Medical Technology Group's market cap is currently $467.13K. The company's EPS TTM is $-0.75; its P/E ratio is -0.04; Regenerative Medical Technology Group has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 5.10M | $ 4.11M | $ 2.41M | $ 1.53M | $ 437.89K |
| Gross Profit | $ 2.81M | $ 2.82M | $ 1.68M | $ 876.97K | $ 150.14K |
| Operating Income | $ -867.16K | $ 81.18K | $ -715.23K | $ -1.18M | $ -9.93M |
| EBITDA | $ -83.56K | $ 301.74K | $ -3.01M | $ -1.02M | $ -10.11M |
| Net Income | $ -7.81M | $ -5.56M | $ -9.81M | $ -5.49M | $ -12.88M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 956.72K | $ 1.17M | $ 530.54K | $ 1.65M | $ 2.98M |
| Total Assets | $ 4.49M | $ 3.82M | $ 2.88M | $ 8.08M | $ 9.31M |
| Total Debt | $ 19.57M | $ 20.05M | $ 17.65M | $ 15.14M | $ 13.37M |
| Net Debt | $ 18.61M | $ 18.88M | $ 17.12M | $ 13.50M | $ 10.39M |
| Total Liabilities | $ 39.23M | $ 31.18M | $ 24.67M | $ 20.06M | $ 16.06M |
| Stockholders' Equity | $ -34.75M | $ -27.36M | $ -21.80M | $ -11.98M | $ -6.76M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.31M | $ 635.28K | $ -804.80K | $ -1.31M | $ -9.88M |
| Operating Cash Flow | $ -706.52K | $ 850.70K | $ -419.20K | $ -1.11M | $ -9.88M |
| Investing Cash Flow | $ -602.58K | $ -215.42K | $ -385.60K | $ -198.43K | $ 666.47K |
| Financing Cash Flow | $ 1.10M | $ 0.00 | $ -309.85K | $ -20.78K | $ 12.15M |
Currency in USD